Medici (688202.SH) made a pre-profit. Net profit from the mother is expected to be 42 million yuan to 63 million yuan for half a year, turning a loss into a profit

According to Zhitong Finance App News, Medici (688202.SH) announced that the company expects net profit attributable to owners of the parent company to turn a loss into a profit in the first half of 2026, from 42 million yuan to 63 million yuan. Compared with the same period last year (statutory disclosure data), it is expected to increase 54.9 million yuan to 75.9 million yuan.

Mainly, global demand for innovative drug research and development is showing a clear recovery trend. Increased market demand drives business volume and pricing to improve at the same time. Adequate order reserves have laid a solid foundation for healthy performance growth. Relying on the core competitiveness of pre-clinical integrated R&D platforms, the company continues to cultivate domestic and foreign markets to improve the efficiency of project implementation and delivery, and achieve a year-on-year increase in revenue by about 40%; capacity utilization increases effectively dilutes fixed unit costs, and continuously optimizes the cost structure; At the same time, the company continues to deepen quality and efficiency management to promote steady improvement in human efficiency. Steady improvement.